Navigation Links
Smith & Nephew Orthopaedics and BrainLAB Announce Exclusive Computer-Assisted Surgery Development Agreement
Date:2/25/2009

MEMPHIS, Tenn. and MUNICH, Feb. 25 /PRNewswire/ -- Smith & Nephew's Orthopaedics business and BrainLAB today announce an agreement by which BrainLAB will become the exclusive vendor for developing and supporting computer-assisted surgical technologies for Smith & Nephew's high performance hip and knee implants.

Starting in March 2009, Munich-based BrainLAB will begin work integrating the Smith & Nephew portfolio of instruments, implants and pre-existing navigation technology into their proprietary systems. BrainLAB's expertise and leading market share will extend the success of Smith & Nephew in this arena, building on the innovations introduced within the implant maker's PiGALILEO system. For instance, the exclusive PiGALILEO ACCULIGN(TM) motorized positioning guide will be a central component of future development, and will remain exclusive to Smith & Nephew implant-specific applications.

"Relying exclusively on navigation from BrainLAB, the market and technology leader for computer assisted surgery, Smith & Nephew can focus more of our resources on our core business - the design, development, marketing and sale of orthopaedic implants," says Joseph DeVivo, president of Smith & Nephew Orthopaedics. "This supports our strategy to be the preferred brand of active patients while partnering with healthcare professionals to deliver innovative hip, knee and trauma portfolios."

Under the agreement, Smith & Nephew will provide marketing, sales support, training, and post-installation clinical support, while BrainLAB will execute sales of the navigation equipment, as well as applications training and service. Smith & Nephew will continue to support its base of existing computer-navigation customers who use its PiGALILEO and AchieveCAS(TM) systems.

This is not the first agreement between the two companies. Since 2003, BrainLAB has introduced applica
'/>"/>

SOURCE Smith & Nephew
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Smith & Nephew Endoscopys OSTEORAPTOR(TM) Anchor Provides Bioabsorbable Solution for Labral Tears in the Hip and Shoulder
2. Smith & Nephew Announce the New RENASYS EZ(TM) System for Negative Pressure Wound Therapy
3. Activplant Corporation Announces Global Agreement with GlaxoSmithKline
4. U.S. Court of Appeals Rules That Smith & Nephew Does Not Infringe KCI Patents
5. Smith & Nephew Announces Agreement with the OREF Regarding Grants to Support Research and Education in Orthopaedics
6. Smithfield Foods Lean Generation(R) Deli Partnership with National Breast Cancer Foundation Celebrates $135,000 Contribution
7. GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer
8. Houlihan Smith Arranges Equity Investment Into Tri-Tech Health, LLC
9. Orthopaedic Surgeon Kevin Smith, MD, Joins Northwest Hospital & Medical Center and The Sports Medicine Clinic
10. GlaxoSmithKlines Drug Will Become New Clinical Gold Standard by 2012 for the Treatment of Relapsed/Refractory CLL
11. GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...vehicles may reduce future disease burden, researc...News) -- Encouraging city dwellers to walk and bic...r public health benefits than increased used of lo..., The study compared the projected health effec...narios for London, England, and Delhi, India: bus...
(Date:11/27/2009)...h™ announced today that Spectrum Health (Gra...terprise orthopedic templating solution and its Tr... (PRWEB) November 27, 2009 -- Voyant Hea...rand Rapids, Michigan) has licensed its TraumaCad ...TraumaCad Extend workflow solution, to allow its o...
(Date:11/27/2009)...teractive anatomy education apps from Modality and...ciences learning opportunities for iPhone and iPod...s) November 27, 2009 -- Modality, Inc. and Lippi...Wolters Kluwer Health, today announced the availab...pp Store. Clemente’s Anatomy, Rohen’s ...
(Date:11/26/2009)...Americans living with diabetes will nearly double,...ion in 2034. Over the same period, spending on dia... to $336 billion, even with no increase in the pre...rsity of Chicago report in the December issue of ...tes covered by Medicare will rise from 8.2 million...
(Date:11/26/2009)...otional rollercoaster, study finds , , T...ear factor meets the jubilant sports fan. , A n...ose who root for the winning team -- enjoy the gre...ch and victory was in doubt, producing feelings of...anksgiving weekend as you,re glued to the TV set, ...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
... Therapy Appears Superior to Standard Therapy for ...omized, controlled trials comparing sequential and...nted, previously untreated H. pylori infection fo...irm these findings, 10-day sequential therapy coul...
... 19 Zimmer Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH)...the,Company as Group President, Global Businesses....mer Dental, Zimmer Trauma, Zimmer Orthopaedic Surg...and Chief Executive Officer., "We are delighted t...
...tion Company Provides Development Expertise for Pa...lth Platform, PORTLAND, Ore., May 19 Mount Tabor...n and development company, announced,collaboration... headquarters today; the product allows users to s...
... polyalkylimide implant injections leaves skin ope...y 19 (HealthDay News) -- Cosmetic skin fillers cal...frequent, but sometimes severe, immune-related sid...ial features such as the lips, cheeks, forehead an...
...ing ED increased risk in diabetic men , , ...wo studies of men with diabetes add to the evidenc...y warning sign for serious heart disease. , A Hong...ly to have a heart attack or other major cardiac p...
...om University Hospitals Case Medical Center (UHCMC...der-- with malignant brain tumors are not treated ...s old. Furthermore, the researchers find that if ...pril issue of the Journal of Neurosurgery. , Usin...
Other Medicine News:Health News:Zimmer Holdings Names Mark C. Throdahl Group President, Global Businesses 2Health News:Zimmer Holdings Names Mark C. Throdahl Group President, Global Businesses 3Health News:Zimmer Holdings Names Mark C. Throdahl Group President, Global Businesses 4Health News:Mount Tabor Collaborates with Google Health 2Health News:Cosmetic Skin Fillers May Cause Delayed Side Effects 2Health News:Erectile Dysfunction a Strong Harbinger of Heart Trouble 2Health News:Erectile Dysfunction a Strong Harbinger of Heart Trouble 3Health News:Study: Patients 75 years and older with brain tumors may benefit from more aggressive treatment 2
(Date:11/25/2009)...A, Switzerland, Nov. 25 From Nove...novative hearing solutions, presented the second e...focusing on the special needs of the older populat...ts in aging and audiology from around the world an...older people with hearing loss for an opportunity ...
(Date:11/25/2009)..., Nov. 25 The FDA granted traditio...ets, a non-nucleoside reverse transcriptase inhibi...lly indicated for use in treatment-experienced adu...V-1 strains resistant to an NNRTI and other antire...s based on 48-week data from two Phase 3 studies k...
(Date:11/25/2009)...Md., Nov. 25 Remedium T...ream-like foam that stops severe bleeding, won fir...y Idea category of the Global Security Challenge 2...ted from more than 100 entries from around the wor... GSC Security Summit conference held at the London...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 1Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 2Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 3TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 1TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 2TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 3TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 4More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 1More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 2More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 3More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 4
...ical Company,Limited (Takeda) announced today that...ch & Development Center, Inc. (U.S.), submitted a ...ug Administration (FDA) for,marketing approval of ...l),("alogliptin/ACTOS") in a single tablet for the...scovered by Takeda,s wholly owned subsidiary, Take...
...er Supports Spiriva,s Safety,Profile, RIDGEFIELD,...m and Pfizer Inc have released a new analysis of 3... UPLIFT, confirming the long term,safety profile o...alation,powder). The new and expanded safety data ... article by Singh et al. published in the Septembe...
Other Medicine Technology:Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes 2Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes 3Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT 2Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT 3Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT 4Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT 5
Fineline EZ
Tendril DX Model 1388 K
Pediatric 6491
Flextend Model 4086
Medicine Products: